Bausch Health Companies (BHC) Income from Non-Controlling Interests (2013 - 2026)

Bausch Health Companies (BHC) reported Income from Non-Controlling Interests of -$8.0 million for Q1 2026, up 71.43% on a YoY basis from -$4.7 million in Q1 2025, and down 188.89% sequentially from $9.0 million in Q4 2025.

Bausch Health Companies (BHC) Income from Non-Controlling Interests (2013 - 2026) Analysis & Trends

Bausch Health Companies (BHC) has 14 years of Income from Non-Controlling Interests data on file, last reported at -$8.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Income from Non-Controlling Interests rose 71.43% year-over-year to -$8.0 million; the trailing twelve-month figure through Mar 2026 stood at -$17.0 million (up 58.54% YoY), and the FY2025 full-year result was -$37.0 million, down 42.31% from the prior year.
  • Income from Non-Controlling Interests fell to -$8.0 million in Q1 2026, from $9.0 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $9.0 million in Q4 2025 to a low of -$28.0 million in Q1 2025.
  • A 5-year average of -$4.8 million and a median of -$5.5 million in 2023 frame the typical range for Income from Non-Controlling Interests.
  • Across the five-year window, Income from Non-Controlling Interests surged 200.0% in 2022 and plunged 1200.0% in 2024, its largest moves.
  • Tracing BHC's Income from Non-Controlling Interests over 5 years: stood at $4.0 million in 2022, then tumbled by 300.0% to -$8.0 million in 2023, then jumped by 162.5% to $5.0 million in 2024, then soared by 80.0% to $9.0 million in 2025, then tumbled by 188.89% to -$8.0 million in 2026.
  • Business Quant data shows BHC's Income from Non-Controlling Interests at -$8.0 million in Q1 2026, $9.0 million in Q4 2025, and $2.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 395,346.10
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn -12.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -
10 Bausch Health Companies 1.65 Bn 333.91 Mn 2.52 Bn -8.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.00 Mn
Dec 31, 2025 9.00 Mn
Sep 30, 2025 2.00 Mn
Jun 30, 2025 -20.00 Mn
Mar 31, 2025 -28.00 Mn
Dec 31, 2024 5.00 Mn
Sep 30, 2024 -7.00 Mn
Jun 30, 2024 -11.00 Mn
Mar 31, 2024 -13.00 Mn
Dec 31, 2023 -8.00 Mn
Sep 30, 2023 -4.00 Mn
Jun 30, 2023 1.00 Mn
Mar 31, 2023 -8.00 Mn
Sep 30, 2022 4.00 Mn
Jun 30, 2022 6.00 Mn
Mar 31, 2022 3.00 Mn
Dec 31, 2021 3.00 Mn
Sep 30, 2021 3.00 Mn
Jun 30, 2021 2.00 Mn
Mar 31, 2021 3.00 Mn